home / Greece / Evrofarma SA

Evrofarma SA Market Cap

$29.10 M

-78,428 Dollars

ATHEX:EVROF.AT · April 20, 2025

Share price

$2.13

Enterprise Value

$42.04 M

Change (1-Year)

25.5%

Global Rank

#8388

Country Rank

#68

Regions

Greece

Market cap

As of April 20, 2025, Evrofarma SA (EVROF.AT) has a market cap of $29.097 million USD. According to our data, Evrofarma SA is ranked No.8388 in global market value.

Sector Rank:

Food #298

EVROF.AT Market Capitalization Growth

1 Years Growth:

25.5%

3 Years Growth:

119.2%

5 Years Growth:

125.3%

10 Years Growth:

498.7%

15 Years Growth:

261.3%

20 Years Growth:

83.1%

Total Growth:

-55%

Evrofarma SA Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Evrofarma SA Market Cap CAGR Chart

Evrofarma SA Market Cap History 2000 - 2025

Year	Market Cap	%Change
Apr 20, 2025	$29.10 M	2.49%
Dec 30, 2024	$28.39 M	55.70%
Dec 28, 2023	$18.23 M	68.54%
Dec 29, 2022	$10.82 M	-21.76%
Dec 30, 2021	$13.83 M	-4.61%
Dec 30, 2020	$14.50 M	-18.11%
Dec 30, 2019	$17.70 M	80.62%
Dec 30, 2018	$9.80 M	95.45%
Dec 28, 2017	$5.01 M	21.32%
Dec 29, 2016	$4.13 M	5.02%
Dec 30, 2015	$3.94 M	17.73%
Dec 30, 2014	$3.34 M	-4.35%
Dec 30, 2013	$3.49 M	-35.75%
Dec 30, 2012	$5.44 M	-26.19%
Dec 29, 2011	$7.37 M	12.79%
Dec 30, 2010	$6.53 M	-44.16%
Dec 30, 2009	$11.70 M	-22.22%
Dec 30, 2008	$15.04 M	-30.66%
Dec 30, 2007	$21.69 M	-19.55%
Dec 28, 2006	$26.97 M	33.02%
Dec 29, 2005	$20.27 M	-16.05%
Dec 30, 2004	$24.15 M	-12.76%
Dec 30, 2003	$27.68 M	27.22%
Dec 30, 2002	$21.76 M	-53.26%
Dec 30, 2001	$46.56 M	-55.29%
Dec 28, 2000	$0.10 B	100%

Similar Companies to Evrofarma SA

Name	Market Cap	Market cap difference	Regions
Pfizer PFE	$125.57 B	0.001 M	USA
Johnson & Johnson JNJ	$379.48 B	-0.003 M	USA
Merck MRK	$196.28 B	0.008 M	USA
Novartis NVS	$219.89 B	0.932 B	Switzerland
Sanofi SNY	$124.64 B	0.327 B	France
GlaxoSmithKline GSK	$72.79 B	-0.000 M	UK
AstraZeneca AZN	$210.29 B	0.735 B	UK
Bristol-Myers Squibb BMY	$100.17 B	-0.004 M	USA
AbbVie ABBV	$306.02 B	0.008 M	USA
Eli Lilly LLY	$754.27 B	0.008 M	USA
Amgen AMGN	$149.09 B	0.124 B	USA
Takeda Pharmaceutical TAK	$46.30 B	0.000 M	Japan
Biogen BIIB	$17.36 B	-0.001 M	USA

About Evrofarma SA Inc.

Name

EVROFARMA S.A. (CR)

Website

https://www.evrofarma.gr

Headquarters

Didymoteicho,None

symbol

EVROF.AT

CURRENCY

EUR

country

Greece

fullTimeEmployees

166

exchange

ATH

firstTradeDateEpochUtc

1970/01/01

EVROF.AT Market Cap Formula

Market Cap	=	EVROF.AT Stock Price	*	EVROF.AT Shares Outstanding
	=	$2.13	*	13.67 M
	=	$29.10 M

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe